Vasodilators for Dogs in Canada: Top 7 Prescription Options for 2026
Published on Wednesday, February 25, 2026
Vasodilator agents relax blood vessels to lower systemic and pulmonary blood pressure in dogs with heart disease or hypertension. Common prescription examples include hydralazine formulations and nitrates, and selective pulmonary vasodilators such as sildenafil. These medicines are frequently used alongside ACE inhibitors, diuretics, or positive inotropes to optimize hemodynamics and symptom control. In Canada, veterinarians and pet owners choose vasodilators based on the type of hypertension (systemic versus pulmonary), route and flexibility of dosing (tablet, ointment, or compounded suspension), safety profile and monitoring needs, and local availability. For many owners the appeal comes from documented clinical benefit, straightforward outpatient dosing, and access to veterinary guidance and compounding services across Canada that make precise dosing easier for small or difficult to dose patients. This category covers prescription-only options, practical dosing forms, and factors that influence product selection for canine cardiovascular care in the Canadian market.
Top Picks Summary
What the research and clinical guidance say
Veterinary research and clinical practice support the use of vasodilators to manage systemic and pulmonary hypertension in dogs when indicated. Different drug classes target different parts of the circulation: nitrates and hydralazine primarily reduce systemic afterload or provide topical vasodilation, while sildenafil and other phosphodiesterase-5 inhibitors selectively lower pulmonary vascular resistance. Evidence comes from clinical trials, case series, and consensus guidance showing symptom improvement, better exercise tolerance, and measurable hemodynamic changes in appropriately selected patients. Safety and monitoring data emphasize dose titration, regular blood pressure checks, and assessment of renal function and electrolytes when vasodilators are used in combination with other cardiac drugs.
Sildenafil has consistent evidence for improving signs and echocardiographic measures in dogs with pulmonary hypertension and is widely used in veterinary practice.
Hydralazine and nitrates (including topical nitroglycerin) are effective in lowering systemic afterload and can be useful for acute or refractory systemic hypertension when combined with other agents.
Compounded oral suspensions allow accurate, small-dose administration for toy and pediatric patients where tablet dosing is impractical.
Combination therapy (for example, vasodilators plus ACE inhibitors or diuretics) often produces better hemodynamic control than single-agent therapy, but requires more frequent monitoring to avoid hypotension or renal complications.
Veterinary guidelines and multiple clinical reports recommend monitoring blood pressure, renal parameters, and clinical signs after starting or changing vasodilator therapy to balance benefit and safety.
Frequently Asked Questions
Which vasodilator is best for pulmonary hypertension dogs?
For pulmonary hypertension, Sildenafil 20mg Tablets are the lead pulmonary vasodilator, with an average rating of 4.5, using 20 mg PDE-5 inhibitor tablets to target pulmonary arterial pressure rather than systemic afterload.
How does Apresoline 10mg tablets reduce blood pressure?
Apresoline (Hydralazine) 10mg Tablets are 10 mg oral tablets used off-label to reduce systemic vascular resistance and afterload in hypertensive or heart-failure dogs by acting as a direct smooth muscle relaxant for systemic vasodilation.
What price and value does Nitro-Bid ointment offer?
Nitro-Bid (Nitroglycerin) 2% Ointment is a 2% topical nitroglycerin ointment for fast-acting vasodilation, but no price or warranty duration is provided for this product in the data.
Can I use Nitro-Bid if my dog can’t take pills?
Nitro-Bid (Nitroglycerin) 2% Ointment can be useful when oral administration is impractical because it’s transdermal; the data lists human exposure and sensitization risk, plus careful application to monitor hypotension and local skin irritation.
Conclusion
In Canada the vasodilator options available for dogs combine evidence-based effectiveness with practical dosing choices and compounding support. The main products covered here include Apresoline (Hydralazine) 10mg Tablets, Sildenafil 20mg Tablets, Nitro-Bid (Nitroglycerin) 2% Ointment, Hydralazine Compounded Oral Suspension, Isordil (Isosorbide Dinitrate) 10mg Tablets, Viagra (Sildenafil) 25mg Tablets, and Amlodipine 1.25mg Compounded Oral Suspension. For canine pulmonary hypertension, Sildenafil 20mg Tablets is often considered the best single choice because of its targeted action, clinical track record, and availability; for systemic hypertension or small patients, hydralazine or a compounded amlodipine suspension may be preferred depending on the case. I hope you found the information you were looking for; you can refine or expand your search using the site search to compare dosing, safety profiles, and availability across Canadian pharmacies and compounding services.
